Previous Close | 278.23 |
Open | 278.03 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 272.13 - 279.50 |
52 Week Range | 154.39 - 299.06 |
Volume | 493,537 |
Avg. Volume | 356,656 |
Market Cap | 17.065B |
Beta (5Y Monthly) | 0.82 |
PE Ratio (TTM) | 32.76 |
EPS (TTM) | 8.36 |
Earnings Date | Apr 26, 2021 - Apr 30, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Nov 26, 1996 |
1y Target Est | 274.62 |
Waters Corporation (NYSE:WAT) today announced it has entered a reseller agreement with TetraScience, a cloud technology innovator powering transformational changes in life sciences R&D. Through the partnership, Waters will now offer its customers the Empower™ Data Science Link, powered by TetraScience. This unique technology pairs Waters’ industry-leading, compliance-ready Empower Chromatography Data System (CDS) with TetraScience’s Data Platform and data science tools, providing unparalleled insights into chromatography data.
Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the Cowen Healthcare Conference virtually on Wednesday, March 3rd, 2021 at 2:40PM Eastern Standard Time.
The new ACQUITY PREMIER Solution improves the sensitivity, analyte recoveries, and assay-to-assay reproducibility of LC, LC-MS and LC-MS/MS analyses.